Friday, July 10, 2026

biotech · HER2 Positive Breast Cancer

Prestige BioPharma

Prestige BioPharma clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Seoul, KR HQ
1 Employees
EMA registrant Type
Company details
Status
Public
HQ
Seoul, KR
Employees
1
Programs
2
Drugs
0
Patents
0
Intelligence · Clinical Programs

Prestige BioPharma projects

1 ClinicalTrials.gov programs sponsored by Prestige BioPharma.

Prestige BioPharma has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. HD201

    Prestige Biopharma Belgium

    HER2 Positive Breast Cancer

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Prestige BioPharma have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.